A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics

NCT03850873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: TQB3616

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.